• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation

    9/25/25 9:00:00 AM ET
    $HQY
    Real Estate
    Real Estate
    Get the next $HQY alert in real time by email

    DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced the appointment of new senior executives to accelerate the company's strategic vision and capitalize on expanding market opportunities. Mukund Ramachandran joins as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management, effective September 29, 2025.

    The appointments come as HealthEquity continues to execute against record financial performance, alongside the largest HSA eligibility expansion in 20 years following recent federal legislation.

    The legislation represents significant market expansion opportunities, allowing Direct Primary Care arrangements, low-cost telehealth services, and all individual Bronze and Catastrophic ACA plans to be coupled with HSAs beginning January 1, 2026. With over 7M people currently enrolled in bronze plans and approximately 90% of these plans previously ineligible for HSAs, HealthEquity is uniquely positioned to capture this expanded market through its broad partner network and enhanced consumer enrollment experience.

    Mukund Ramachandran Appointed Chief Marketing Officer

    Ramachandran brings more than 25 years of B2B marketing and communications leadership across fintech, adtech, and martech. Most recently, he served as SVP, Head of B2B Marketing for Commercial & New Payment Flows at Mastercard, where he shaped global messaging, advanced sales enablement, and executed integrated marketing programs that fueled significant growth. Prior to Mastercard, he was a senior marketing leader at Dynamic Yield (later acquired by Mastercard), where he helped transform the company from a startup into a recognized category leader. Earlier in his career, he held marketing and strategy positions across the media and technology sectors, further broadening his expertise in scaling brands and driving market adoption.

    In his new role, Ramachandran will be responsible for developing and executing HealthEquity's enterprise-wide marketing strategy. He will lead product marketing and go-to-market execution, while overseeing execution and strategies to strengthen brand reputation and engagement across both B2B and B2C audiences.

    Garett Kitch Named SVP, Client Sales & Relationship Management

    Kitch joins HealthEquity with two decades of experience building and leading high-performing sales teams in tech-enabled businesses. As Chief Sales Officer at EverQuote, he led revenue-generating functions for the publicly traded insurtech company. Previously, Kitch served in progressive leadership roles at eHealth, Inc., where he led Medicare sales operations with P&L responsibility for $420M in revenue and managed teams of over 2,200 members. He also held senior positions at Vivint, where he established the Channel Partner division from startup to major acquisition channel.

    Kitch will define and implement HealthEquity's multi-year sales strategy focused on organic growth, new logo acquisition, and expansion across direct and partner-assisted channels. He will lead efforts to build executive-level relationships with key clients, brokers, and strategic partners while developing differentiated engagement strategies by client segment.

    Driving Strategic Vision and Innovation

    The new leadership appointments support HealthEquity's strategic focus on leveraging technology innovation to enhance member and client experiences. The company continues to advance its AI-powered solutions, including expedited claims processing that has automated millions of dollars in reimbursements while improving member satisfaction and reducing costs. HealthEquity's Assist portfolio and Member First Secure Mobile Experience, which now boasts 1.7M downloads, demonstrate the company's commitment to technological excellence.

    "These key additions to our executive team strengthen our ability to execute against our vision of helping Americans better save, spend, and invest for health. As we capitalize on the largest HSA expansion in 20 years and continue innovating with AI-powered solutions, Mukund and Garett will bring the expertise and leadership needed to drive our next phase of growth," said Michael Fiore, Chief Commercial Officer. "Mukund's proven track record of building high-performance marketing organizations and driving measurable pipeline growth makes him the ideal leader to elevate our brand and accelerate customer acquisition, while Garett's exceptional track record of scaling sales organizations aligns perfectly with our mission to expand market leadership. Their combined experience in financial services, insurance, and both B2B and B2C marketing will be invaluable as we modernize our approach and expand our reach to new consumer segments through recent legislative changes."

    Both Ramachandran and Kitch will report to Fiore, strengthening HealthEquity's go-to-market capabilities as the company pursues new consumer-driven strategies while maintaining its leadership position with employers and partners.

    About HealthEquity

    HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for more than 17 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who share our mission to better save and improve lives by empowering healthcare consumers. For more information, visit www.healthequity.com.

    Media Contact

    Atiya Easterling

    pr@healthequity.com



    Primary Logo

    Get the next $HQY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HQY

    DatePrice TargetRatingAnalyst
    4/9/2026$105.00Market Perform → Outperform
    BMO Capital Markets
    1/9/2026$89.00Neutral → Sell
    Goldman
    12/9/2025$118.00Overweight
    Barclays
    11/13/2025$100.00Market Perform
    BMO Capital Markets
    5/22/2025$105.00 → $112.00Outperform
    RBC Capital Mkts
    3/25/2025$120.00 → $115.00Outperform → Strong Buy
    Raymond James
    12/4/2024$126.00Outperform
    Mizuho
    11/15/2024$108.00Neutral
    Goldman
    More analyst ratings

    $HQY
    SEC Filings

    View All

    SEC Form 144 filed by HealthEquity Inc.

    144 - HEALTHEQUITY, INC. (0001428336) (Subject)

    5/29/26 4:23:30 PM ET
    $HQY
    Real Estate

    SEC Form 10-Q filed by HealthEquity Inc.

    10-Q - HEALTHEQUITY, INC. (0001428336) (Filer)

    5/28/26 4:04:25 PM ET
    $HQY
    Real Estate

    HealthEquity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHEQUITY, INC. (0001428336) (Filer)

    5/28/26 4:03:03 PM ET
    $HQY
    Real Estate

    $HQY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF COMMERCIAL OFFICER Fiore Michael Henry sold $298,490 worth of shares (3,142 units at $95.00) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 59,113 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    6/2/26 5:03:25 PM ET
    $HQY
    Real Estate

    Director Wellborn Gayle Furgurson exercised 2,439 shares at a strike of $47.21 and sold $219,510 worth of shares (2,439 units at $90.00) as part of a pre-agreed trading plan (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    6/1/26 6:04:39 PM ET
    $HQY
    Real Estate

    EVP, General Counsel Ladd Delano sold $675,000 worth of shares (7,500 units at $90.00) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 91,141 units (SEC Form 4)

    4 - HEALTHEQUITY, INC. (0001428336) (Issuer)

    6/1/26 6:02:09 PM ET
    $HQY
    Real Estate

    $HQY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

    Increases Repurchase Program by $1.0 Billion Highlights of the first quarter include: Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year.Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.Revenue increased 7% to $354.6 million.Net income per diluted share rose 34% to $0.82 from $0.61 one year ago, and non-GAAP net income per diluted share increased 28% to $1.24.Total HSA Assets grew 19% to $37.1 billion.Returned $123.0 million to shareholders through stock repurchases. DRAPER, Utah, May 28, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company

    5/28/26 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

    DRAPER, Utah, May 05, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its first quarter of fiscal 2027, after the close of regular stock market trading on Thursday, May 28, 2026. Following the news release, HealthEquity management will host a conference call for investors on Thursday, May 28, 2026, at 4:30 p.m. Eastern Time during to review the Company's first quarter results. HealthEquity First Quarter Fiscal Year 2027 Results Conference CallDate:May 28, 2026Time

    5/5/26 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

    DRAPER, Utah, March 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that William ‘Bill' Gassen, president and chief executive officer of Sanford Health, has been elected to its board of directors (the "Board") effective March 26, 2026. He will also serve on the Audit and Risk Committee and Talent, Compensation and Culture Committee of the Board. His appointment expands the Board to 10 directors, eight of whom are independent. "Bill brings deep insight into how care is delivered, how it is financed

    3/30/26 8:30:00 AM ET
    $HQY
    $OSCR
    Real Estate
    Medical Specialities
    Health Care

    $HQY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HealthEquity upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded HealthEquity from Market Perform to Outperform and set a new price target of $105.00

    4/9/26 8:22:37 AM ET
    $HQY
    Real Estate

    HealthEquity downgraded by Goldman with a new price target

    Goldman downgraded HealthEquity from Neutral to Sell and set a new price target of $89.00

    1/9/26 8:49:40 AM ET
    $HQY
    Real Estate

    Barclays initiated coverage on HealthEquity with a new price target

    Barclays initiated coverage of HealthEquity with a rating of Overweight and set a new price target of $118.00

    12/9/25 8:49:54 AM ET
    $HQY
    Real Estate

    $HQY
    Financials

    Live finance-specific insights

    View All

    HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance

    Increases Repurchase Program by $1.0 Billion Highlights of the first quarter include: Net income increased 29% to $69.4 million, and net income margin increased to 20% from 16% last year.Adjusted EBITDA increased 17% to $164.5 million, and Adjusted EBITDA margin increased to 46% from 42% last year.Revenue increased 7% to $354.6 million.Net income per diluted share rose 34% to $0.82 from $0.61 one year ago, and non-GAAP net income per diluted share increased 28% to $1.24.Total HSA Assets grew 19% to $37.1 billion.Returned $123.0 million to shareholders through stock repurchases. DRAPER, Utah, May 28, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company

    5/28/26 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule

    DRAPER, Utah, May 05, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced plans to release financial results for its first quarter of fiscal 2027, after the close of regular stock market trading on Thursday, May 28, 2026. Following the news release, HealthEquity management will host a conference call for investors on Thursday, May 28, 2026, at 4:30 p.m. Eastern Time during to review the Company's first quarter results. HealthEquity First Quarter Fiscal Year 2027 Results Conference CallDate:May 28, 2026Time

    5/5/26 4:01:00 PM ET
    $HQY
    Real Estate

    HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

    Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion.Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.Net income per diluted share rose to $2.46 from $1.09 one year ago, and non-GAAP net income per diluted share increased 28% to $4.00.Adjusted EBITDA increased 20% to $566.0 million, and Adjusted EBITDA margin increased to 43% from 39% last year.Total HSA Assets grew 14% to $36.5 billion.Returned $301.7 million to shareholders through stock repurchases.Further reduced HSA cash repricing risk with a cumulative $2.35 billion 5-year Treasury bond hedge at 3.92%. Highlights of the fourth quarter include: Revenue incre

    3/17/26 4:01:00 PM ET
    $HQY
    Real Estate

    $HQY
    Leadership Updates

    Live Leadership Updates

    View All

    HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors

    DRAPER, Utah, March 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that William ‘Bill' Gassen, president and chief executive officer of Sanford Health, has been elected to its board of directors (the "Board") effective March 26, 2026. He will also serve on the Audit and Risk Committee and Talent, Compensation and Culture Committee of the Board. His appointment expands the Board to 10 directors, eight of whom are independent. "Bill brings deep insight into how care is delivered, how it is financed

    3/30/26 8:30:00 AM ET
    $HQY
    $OSCR
    Real Estate
    Medical Specialities
    Health Care

    HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation

    DRAPER, Utah, Sept. 25, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest Health Savings Accounts (HSAs) and consumer-directed benefits administrator, today announced the appointment of new senior executives to accelerate the company's strategic vision and capitalize on expanding market opportunities. Mukund Ramachandran joins as Chief Marketing Officer and Garett Kitch as Senior Vice President of Client Sales & Relationship Management, effective September 29, 2025. The appointments come as HealthEquity continues to execute against record financial performance, alongside the largest HSA eligibility expansion in 20 years following recent federal legislation.

    9/25/25 9:00:00 AM ET
    $HQY
    Real Estate

    HealthEquity Reports Year-End Sales Metrics

    DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ:HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian, today announced its HSAs, HSA Assets and Total Accounts as of its fiscal year ended January 31, 2025. The Company also affirmed its guidance for fiscal 2025 and 2026, provided an updated HSA cash repricing schedule, and announced upcoming events and presentations. The total number of HSAs as of January 31, 2025 was 9.9 million, an increase of 14%, from 8.7 million as of January 31, 2024. The Company closed its fiscal year 2025 with 17.0 million Total Accounts, an increase of 9%, from 15.7 million as of January 31,

    2/18/25 4:01:00 PM ET
    $HQY
    Real Estate

    $HQY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/13/24 5:06:19 PM ET
    $HQY
    Real Estate

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/9/24 4:15:05 PM ET
    $HQY
    Real Estate

    SEC Form SC 13G/A filed by HealthEquity Inc. (Amendment)

    SC 13G/A - HEALTHEQUITY, INC. (0001428336) (Subject)

    2/9/24 9:16:06 AM ET
    $HQY
    Real Estate